Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments

Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments

Jan 22, 2024 | Diabetes Business, Featured, Research News, Technology Updates

embecta Announces FDA 510(k) Submission for Insulin Patch Pump announced by Embecta, 9 January 2024. Embecta Corp., a global diabetes care company with a 100-year legacy in insulin delivery, announced that it has submitted a 510(k) premarket filing to the U.S. Food...
Savvy Updates 1/15/24: t:slim X2 Integrates with Libre 2, Vertex Pauses VX-880 Trial, Dexcom to Launch CGM for T2Ds, Loneliness of T1D carers, NEW US-based TRIAL: Diamyd

Savvy Updates 1/15/24: t:slim X2 Integrates with Libre 2, Vertex Pauses VX-880 Trial, Dexcom to Launch CGM for T2Ds, Loneliness of T1D carers, NEW US-based TRIAL: Diamyd

Jan 15, 2024 | Diabetes Business, Featured, Research News, Technology Updates

Tandem integrates t:slim X2 insulin pump with Abbott’s FreeStyle sensor on GlobalData.com, 9 January 2024. Abbott has announced that Tandem Diabetes Care’s t:slim X2 insulin pump has become the first automated insulin delivery (AID) system to integrate with its...
Savvy Updates 1/8/24: PharmSens Submits for Patch Pump, FDA OKs Florida to Import Drugs from Canada, Battery-Independent Fluorescent Nanosensor in Development, Heat & Hypo Risk in Older T1Ds, GlucoTrack Implantable BG Monitor Trials, Apple Watches Back on Sale

Savvy Updates 1/8/24: PharmSens Submits for Patch Pump, FDA OKs Florida to Import Drugs from Canada, Battery-Independent Fluorescent Nanosensor in Development, Heat & Hypo Risk in Older T1Ds, GlucoTrack Implantable BG Monitor Trials, Apple Watches Back on Sale

Jan 8, 2024 | Diabetes Business, Research News, Technology Updates

PharmaSens submits insulin patch pump for FDA approval PharmaSens announced that it applied for FDA approval for its Niia Essential insulin patch pump system. FDA submission follows the pump’s recent ISO 13485 certification for the Switzerland-based company. This...
Savvy Updates, 1/2/24: Apple Stops Selling Series 9/Ultra2, Smart Insulin Research, Zealand & Glucagon, Nightscout App in Top 10, Afrezza Hacks, Docs & EMR Messaging, Off-Topic – Toast

Savvy Updates, 1/2/24: Apple Stops Selling Series 9/Ultra2, Smart Insulin Research, Zealand & Glucagon, Nightscout App in Top 10, Afrezza Hacks, Docs & EMR Messaging, Off-Topic – Toast

Jan 2, 2024 | Diabetes Business, Featured, Research News, Technology Updates

Apple to halt sales of some Apple Watches in US by Samantha Murphy Kelly for CNN.com, 18 December 2023. Apple plans to stop selling some versions of the Apple Watch in the United States to get ahead of what could be one of the most momentous patent disputes in...
Skip to content